Capricor Therapeutics
CAPR
#5617
Rank
HK$10.93 B
Marketcap
HK$188.88
Share price
1.18%
Change (1 day)
142.37%
Change (1 year)

Capricor Therapeutics (CAPR) - Total debt

Total debt on the balance sheet as of March 2026 : HK$0.11 Billion

According to Capricor Therapeutics 's latest financial reports the company's total debt is HK$0.11 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Capricor Therapeutics - Total debt on balance sheet (from 2002 to 2026)

Total debt by year

Year Total debt Change
2024-12-31HK$11.26 M-35.49%
2023-12-31HK$17.46 M-12.7%
2022-12-31HK$20 M-10.63%
2021-12-31HK$22.38 M807.45%
2020-12-31HK$2.46 M
2017-12-31N/A-100%
2016-12-31HK$0.10 B51.95%
2015-12-31HK$70.96 M-0.07%
2014-12-31HK$71.01 M131.17%
2013-12-31HK$30.72 M
2006-12-31HK$0.97 M80.23%
2005-12-31HK$0.53 M33.22%
2004-12-31HK$0.4 M41.04%
2003-12-31HK$0.28 M379.68%
2002-12-31HK$0.05 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$431.30 B 371,818.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$3.18 B 2,647.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
HK$10.10 B 8,616.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$14.96 M-87.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$1.03 M-99.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$4.32 M-96.27%๐Ÿ‡บ๐Ÿ‡ธ USA